Volume 23 Issue 3
Mar.  2025
Turn off MathJax
Article Contents
LI Yang*, WANG Kai, SONG Zonggong. Expression and clinical significance of miR-330-3p and AXIN1295aa in gastric cancer[J]. Chinese Journal of General Practice, 2025, 23(3): 392-396. doi: 10.16766/j.cnki.issn.1674-4152.003911
Citation: LI Yang*, WANG Kai, SONG Zonggong. Expression and clinical significance of miR-330-3p and AXIN1295aa in gastric cancer[J]. Chinese Journal of General Practice, 2025, 23(3): 392-396. doi: 10.16766/j.cnki.issn.1674-4152.003911

Expression and clinical significance of miR-330-3p and AXIN1295aa in gastric cancer

doi: 10.16766/j.cnki.issn.1674-4152.003911
Funds:

 LHGJ20210977

  • Received Date: 2024-02-26
    Available Online: 2025-05-14
  •   Objective  miRNA and the Wnt/β-catenin signaling pathway play important roles in the occurrence and development of tumors. This study aims to explore the effects of miRNA-330-3p (miR-330-3p) and axis suppressor protein 1295aa (AXIN1295aa) expression on gastric cancer.  Methods  A total of 130 patients with gastric cancer admitted to Nanyang Second General Hospital from January to October 2020 were selected. The mRNA expression of miR-330-3p and AXIN1295aa in gastric cancer tissues was detected by qRT-PCR. The expression level of AXIN1295aa protein was detected by immunohistochemistry.  Results  The expression levels of miR-330-3p and AXIN1295aa mRNA in gastric cancer tissue were significantly higher (1.79±0.24 and 0.52±0.10) than those in normal gastric mucosal tissue (1.05±0.14 and 0.11±0.03, t=30.382, 40.575, P < 0.05). The positivity rate of AXIN1295aa protein in gastric cancer tissue was 70.77%, significantly higher than that in normal gastric mucosal tissue 37.69% (x2=16.426, P < 0.001). There were statistically significant differences in the expression levels of miR-330-3p and AXIN1295aa among patients with different tumor diameter, differentiation degree, TNM staging, lymph node metastasis, and invasion of the serosal layer (P < 0.05). There was a statistically significant difference in the 3-year survival rate of gastric cancer patients with different levels of miR-330-3p and AXIN1295aa expression (P < 0.01). The combination of miR-330-3p and AXIN1295aa had a high predictive value for 3-year mortality risk in gastric cancer patients (AUC=0.846). There was a positive correlation between miR-330-3p and AXIN1295aa mRNA expression levels in gastric cancer tissue.  Conclusion  The high expression of miR-330-3p and AXIN1295aa in gastric cancer tissues is closely related to postoperative survival of patients, and can be used as a potential prognostic indicator.

     

  • loading
  • [1]
    NIEMINEN A A, KONTTO J, PUOLAKKAINEN P, et al. Long-term gastric cancer risk in male smokers with atrophic corpus gastritis[J]. Scand J Gastroenerro, 2019, 54(2): 145-151. doi: 10.1080/00365521.2019.1566492
    [2]
    秦新裕. 2020年胃癌临床诊治研究进展[J]. 中华胃肠外科杂志, 2021, 24(1): 23-26.

    QIN X Y. Research progression in clinical treatment of gastric cancer in 2020[J]. Chinese Journal of Gastrointestinal Surgery, 2021, 24(1): 23-26.
    [3]
    何长征, 宋建霖, 胡时栋, 等. miRNAs用于肿瘤诊治研究的临床试验进展[J]. 解放军医学院学报, 2020, 41(12): 1265-1269.

    HE C Z, SONG J L, HU S D, et al. Review in clinical trials related to miRNAs in diagnosis and treatment of cancer[J]. Academic Journal of Chinese PLA Medical School, 2020, 41(12): 1265-1269.
    [4]
    华勇, 张秉丽, 李有连. AXINMETTL14在胃癌组织中的表达情况及其与患者临床特征的关系[J]. 癌症进展, 2019, 17(19): 2317-2320, 2355.

    HUA Y, ZHANG B L, LI Y L. Expression of axin and METTL14 in gastric cancer tissues and the relationship with patients' clinical characteristics[J]. Oncology Progress, 2019, 17(19): 2317-2320, 2355.
    [5]
    RODERS S J, HAMILA S A, MITCHELL C A, et al. A late endosome signaling hub that couples PI3Kα and WNT/β-catenin signaling in breast cancer[J]. Mol Cell Oncol, 2021, 8(4): 152-160.
    [6]
    KINA S, IWAKAWA R K, MIUAMOTO S, et al. A molecular signature of well-differentiated oral squamous cell carcinoma reveals a resistance mechanism to metronomic chemotherapy and novel therapeutic candidates[J]. J Drug Target, 2021, 29(10): 1118-1127. doi: 10.1080/1061186X.2021.1929256
    [7]
    曹毛毛, 李贺, 孙殿钦, 等. 2000-2019年中国胃癌流行病学趋势分析[J]. 中华消化外科杂志, 2021, 20(1): 102-109.

    CHAO M M, LI H, SHUN D Q, et al. Epidemiological trend analysis of gastric cancer in China from 2000 to 2019[J]. Chinese Journal of Digestive Surgery, 2021, 20(1): 102-109.
    [8]
    郭鉴婷, 陈俊. 进展期胃癌患者预后的影响因素[J]. 中国卫生工程学, 2021, 20(1): 78-79.

    GUO J T, CHEN J. Factors affecting the prognosis of advanced gastric cancer patients[J]. Chinese Journal of Public Health Engineering, 2021, 20(1): 78-79.
    [9]
    IKEGAME K, HIKAGE M, FUJIYA K, et al. The effect of minimally invasive gastrectomy for gastric cancer on postoperative gallstone formation[J]. World J Surg, 2021, 45(11): 3378-3385.
    [10]
    SUNAKAWA Y, MATOBA R, INOUE E, et al. O-13 Gut microbiome to predict survival time in advanced gastric cancer treated with nivolumab: the DELIVER trial (JACCRO GC-08)[J]. Ann Oncol, 2021, 32(5): S223-S224.
    [11]
    LØVEBDORF M B, SKOV L. miRNAs in inflammatory skin diseases and their clinical implications[J]. Expert Rev Clin Immu, 2015, 11(4): 467-477.
    [12]
    张俏, 周学志, 程赛, 等. 外周血炎性指标在晚期胃癌免疫检查点抑制剂治疗效果及预后价值中的临床研究[J]. 中华全科医学, 2024, 22(2): 198-201, 243. doi: 10.16766/j.cnki.issn.1674-4152.003364

    ZHANG Q, ZHOU X Z, CHENG S, et al. Clinical study on the therapeutic effect and prognostic value of peripheral blood inflammatory indexes in the treatment of advanced gastric cancer with immune checkpoint inhibitors[J]. Chinese Journal of General Practice, 2024, 22(2): 198-201, 243. doi: 10.16766/j.cnki.issn.1674-4152.003364
    [13]
    KIM E J, KIM M, SEO S, et al. Comparison of sinusoidal obstruction syndrome in gastric cancer patients receiving S-1/oxaliplatin versus capecitabine/oxaliplatin[J]. Anticancer Res, 2021, 41(1): 391-402.
    [14]
    TOKUMARU S, KOIZUMI T, SEKINO Y, et al. Lymphocyte-to-monocyte ratio is a predictive biomarker of response to treatment with nivolumab for gastric cancer[J]. Oncology, 2021, 99(10): 1-9.
    [15]
    程丛丛, 李云秀, 袁海涛, 等. Wnt/β-catenin通路成分Axin和TCF4在卵巢癌中的研究进展[J]. 中国生育健康杂志, 2021, 32(1): 83-84, 101.

    CHENG C C, LI Y X, YUAN H T, et al. Research progress on Wnt/β-ccatenin pathway components Axin and TCF4 in ovarian cancer[J]. Chinese Journal of Reproductive Health, 2021, 32(1): 83-84, 101.
    [16]
    MAJDOUBI R, MASMOUDI L, ELHARIF A. Analysis of soil compaction under different wheel applications using a dynamical cone penetrometer[J]. J Terramechanics, 2024, 111(2): 21-30.
    [17]
    王近瑜, 李国平. circ0006152/miR-557/Wnt3a信号轴在非小细胞肺癌A549细胞发生发展中的机制[J]. 中华全科医学, 2024, 22(3): 418-423. doi: 10.16766/j.cnki.issn.1674-4152.003416

    WANG J Y, LI G P. Mechanism of circ0006152/miR-557/Wnt3a signal axis in the genesis and development of non-small cell lung cancer A549 cells[J]. Chinese Journal of General Practice, 2024, 22(3): 418-423. doi: 10.16766/j.cnki.issn.1674-4152.003416
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(4)  / Tables(3)

    Article Metrics

    Article views (28) PDF downloads(4) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return